Pharmacological inhibition of cholinesterase (ChE) enzymes (acetylcholinesterase (AChE) and/or butyrylcholinesterase) is the most common treatment for Alzheimer’s disease (AD) and its associated complications (Grutzendler and Morris, 2001). This evidence concerns the gene BCHE and Alzheimer disease.